These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 17947731)

  • 1. Rational selection of patients for antibacterial prophylaxis after chemotherapy.
    Cullen MH; Billingham LJ; Gaunt CH; Steven NM
    J Clin Oncol; 2007 Oct; 25(30):4821-8. PubMed ID: 17947731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas.
    Cullen M; Steven N; Billingham L; Gaunt C; Hastings M; Simmonds P; Stuart N; Rea D; Bower M; Fernando I; Huddart R; Gollins S; Stanley A;
    N Engl J Med; 2005 Sep; 353(10):988-98. PubMed ID: 16148284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia.
    Bucaneve G; Micozzi A; Menichetti F; Martino P; Dionisi MS; Martinelli G; Allione B; D'Antonio D; Buelli M; Nosari AM; Cilloni D; Zuffa E; Cantaffa R; Specchia G; Amadori S; Fabbiano F; Deliliers GL; Lauria F; Foà R; Del Favero A;
    N Engl J Med; 2005 Sep; 353(10):977-87. PubMed ID: 16148283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of hospitalization for neutropenic complications of chemotherapy in patients with primary solid tumors receiving pegfilgrastim or filgrastim prophylaxis: a retrospective cohort study.
    Weycker D; Malin J; Kim J; Barron R; Edelsberg J; Kartashov A; Oster G
    Clin Ther; 2009 May; 31(5):1069-81. PubMed ID: 19539108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic prophylaxis in chemotherapy-induced neutropenia: time to reconsider.
    Lo N; Cullen M
    Hematol Oncol; 2006 Sep; 24(3):120-5. PubMed ID: 16783844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are shorter courses of filgrastim prophylaxis associated with increased risk of hospitalization?
    Weycker D; Hackett J; Edelsberg JS; Oster G; Glass AG
    Ann Pharmacother; 2006 Mar; 40(3):402-7. PubMed ID: 16492793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical study on fluoroquinolone prophylaxis in neutropenia patients with acute leukemia].
    Qin TJ; Mi YC; Feng SZ; Li DP; Wei JL; Yang DL; Han MZ; Wang JX; Bian SG
    Zhonghua Yi Xue Za Zhi; 2007 May; 87(20):1389-93. PubMed ID: 17785058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of fluoroquinolone prophylaxis on reduced infection-related mortality among patients with neutropenia and hematologic malignancies.
    Reuter S; Kern WV; Sigge A; Döhner H; Marre R; Kern P; von Baum H
    Clin Infect Dis; 2005 Apr; 40(8):1087-93. PubMed ID: 15791505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial prophylaxis in patients with cancer and neutropenia.
    Castagna L; Santoro A
    N Engl J Med; 2006 Jan; 354(1):90-4; author reply 90-4. PubMed ID: 16395831
    [No Abstract]   [Full Text] [Related]  

  • 10. Levofloxacin vs. ciprofloxacin plus phenethicillin for the prevention of bacterial infections in patients with haematological malignancies.
    Timmers GJ; Simoons-Smit AM; Leidekker ME; Janssen JJ; Vandenbroucke-Grauls CM; Huijgens PC
    Clin Microbiol Infect; 2007 May; 13(5):497-503. PubMed ID: 17263835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective, randomized, multicentric, open, comparative study on the efficacy of a prophylactic single dose of 500 mg levofloxacin versus 1920 mg trimethoprim/sulfamethoxazole versus a control group in patients undergoing TUR of the prostate.
    Wagenlehner FM; Wagenlehner C; Schinzel S; Naber KG;
    Eur Urol; 2005 Apr; 47(4):549-56. PubMed ID: 15774257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibacterial prophylaxis in patients with cancer and neutropenia.
    Almyroudis NG; Segal BH
    N Engl J Med; 2006 Jan; 354(1):90-4; author reply 90-4. PubMed ID: 16395832
    [No Abstract]   [Full Text] [Related]  

  • 13. Prophylaxis versus pre-emptive treatment for infective and inflammatory complications of surgical third molar removal: a randomized, double-blind, placebo-controlled, clinical trial with sustained release amoxicillin/clavulanic acid (1000/62.5 mg).
    Lacasa JM; Jiménez JA; Ferrás V; Bossom M; Sóla-Morales O; García-Rey C; Aguilar L; Garau J
    Int J Oral Maxillofac Surg; 2007 Apr; 36(4):321-7. PubMed ID: 17229548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of adding granulocyte colony-stimulating factor to primary prophylaxis with antibiotics in small-cell lung cancer.
    Timmer-Bonte JN; Adang EM; Smit HJ; Biesma B; Wilschut FA; Bootsma GP; de Boo TM; Tjan-Heijnen VC
    J Clin Oncol; 2006 Jul; 24(19):2991-7. PubMed ID: 16682725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic antimicrobial agents and the importance of fitness.
    Baden LR
    N Engl J Med; 2005 Sep; 353(10):1052-4. PubMed ID: 16148291
    [No Abstract]   [Full Text] [Related]  

  • 16. Immediate vs. delayed imipenem treatment in cancer patients with profound neutropenia induced by high-dose chemotherapy: results of a randomized study.
    García-Sáenz JA; Martín M; Casado A; Pérez-Segura P; Manrique I; Flores L; Macias JA; Cámara JC; Perezagua C; Díaz-Rubio E
    Rev Esp Quimioter; 2002 Sep; 15(3):257-63. PubMed ID: 12582429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Febrile neutropenia: highlighting the role of prophylactic antibiotics and granulocyte colony-stimulating factor during standard dose chemotherapy for solid tumors.
    Timmer-Bonte JN; Tjan-Heijnen VC
    Anticancer Drugs; 2006 Sep; 17(8):881-9. PubMed ID: 16940798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of antibiotic prophylaxis in neutropenic patients with hematologic malignancies].
    Delarive P; Baumgartner JD; Glauser MP; Cometta A
    Schweiz Med Wochenschr; 2000 Dec; 130(48):1837-44. PubMed ID: 11132527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibacterial prophylaxis in patients with cancer and neutropenia.
    Freifeld AG; Sepkowitz KA; Martino P; Steven N; Billingham L; Cullen M; Baden LR
    N Engl J Med; 2006 Jan; 354(1):90-4; author reply 90-4. PubMed ID: 16394310
    [No Abstract]   [Full Text] [Related]  

  • 20. Antibacterial prophylaxis in patients with cancer and neutropenia.
    Pasqualotto AC; Rosa DD; Machado AL
    N Engl J Med; 2006 Jan; 354(1):90-4; author reply 90-4. PubMed ID: 16395830
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.